Protagenic Therapeutics Inc (PTIX)
1.32
-0.09
(-6.38%)
USD |
NASDAQ |
May 31, 16:00
1.36
+0.04
(+3.03%)
After-Hours: 20:00
Protagenic Therapeutics Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| September 30, 2011 | -0.678M |
| June 30, 2011 | -1.797M |
| March 31, 2011 | -0.94M |
| December 31, 2010 | -3.041M |
| September 30, 2010 | 0.192M |
| June 30, 2010 | -0.324M |
| March 31, 2010 | 0.494M |
| December 31, 2009 | 4.149M |
| September 30, 2009 | 1.311M |
| June 30, 2009 | 3.939M |
| March 31, 2009 | 5.819M |
| December 31, 2008 | -7.332M |
| September 30, 2008 | 9.602M |
| June 30, 2008 | 13.07M |
| March 31, 2008 | 14.25M |
| Date | Value |
|---|---|
| December 31, 2007 | 12.56M |
| September 30, 2007 | 9.089M |
| June 30, 2007 | 5.40M |
| March 31, 2007 | 4.916M |
| October 31, 2006 | |
| July 31, 2006 | |
| April 30, 2006 | 5.459M |
| January 31, 2006 | |
| October 31, 2005 | |
| April 30, 2003 | 1.558M |
| January 31, 2003 | 1.21M |
| October 31, 2002 | 1.386M |
| July 31, 2002 | 1.721M |
| April 30, 2002 | 2.086M |
| January 31, 2002 | 1.943M |
| October 31, 2001 | 2.275M |
| July 31, 2001 | 2.047M |
| April 30, 2001 | 2.275M |
| January 31, 2001 | 2.545M |
| October 31, 2000 | 2.491M |
| July 31, 2000 | 0.987M |
| April 30, 2000 | 2.91M |
| January 31, 2000 | 2.80M |
| October 31, 1999 | 3.036M |
| July 31, 1999 | -0.107M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Ekso Bionics Holdings Inc | 1.951M |
| Eyenovia Inc | 0.00 |
| Palisade Bio Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.794M |
| Palatin Technologies Inc | 0.00 |